Sort
40,608 grants matching “prostate cancer”
Role of POZ-zinc finger proteins in tumorigenesis.
$340,356Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Community Outreach and Engagement
$340,322Charnita M Zeigler-Johnson · Research Inst Of Fox Chase Can Ctr · P30 · FY2025 · CA
Inhibition of novel molecular targets of prostaglandin formation for antitumor ac
$340,301Emmanuelle Joelle Meuillet · University Of Arizona · R01 · FY2011 · CA
PSMA-based Cancer Imaging Agents
$340,300Martin G Pomper · Johns Hopkins University · R01 · FY2010 · CA
MicroRNAs in Advanced Prostate Cancer: A miR-21 model
$340,300Shawn Lupold · Johns Hopkins University · R01 · FY2010 · CA
Physical and functional probing of DEAD-box proteins as general RNA chaperones
$340,297Rick Russell · University Of Texas At Austin · R01 · FY2013 · GM
BIOCHEMICAL AND GENETIC MARKERS IN AGGRESSIVENESS AND RECURRENCE OF PROSTATE CANCER: RACE-SPECIFIC LINKS TO INFLAMMATION AND INSULIN RESISTANCE
$340,215Wayne State University · · FY2010 · Department of Defense
Clinical and Analytical Validation of Cancer Biomarkers
$340,200Daniel W Chan · Johns Hopkins University · U24 · FY2021 · CA
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy
$340,175Inderbir Gill · University Of Southern California · R01 · FY2018 · CA
Genetically Engineered Viruses for Prostate Cancer Therapy
$340,161Robert L Martuza · Massachusetts General Hospital · R01 · FY2007 · CA
Genetically Engineered Viruses for Prostate Cancer Therapy
$340,161Robert L Martuza · Massachusetts General Hospital · R01 · FY2008 · CA
Increasing Recruitment of underrepresented cancer survivors with awareness enhancing interventions (RUN AWEI)
$340,159Michelle Y Martin · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
$340,155Gregory David · New York University School Of Medicine · R01 · FY2014 · CA
Microtubule dependent AR signaling predicts taxane sensitivity
$340,155Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · CA
Microtubule dependent AR signaling predicts taxane sensitivity
$340,155Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
Resistance and Response Mechanisms to Prostate Cancer Therapy
$340,148Tomasz M Beer · Oregon Health & Science University · R01 · FY2008 · CA
Olympus NanoZoomer RS Whole Slide Imaging System
$340,145Brendan F Boyce · University Of Rochester · S10 · FY2010 · RR
Identifying genetic vulnerabilities in neuroendocrine prostate cancer
$340,139Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
DEVELOPMENT OF PET RADIOPHARMACEUTICALS TARGETING GRPR
$340,134Buck E Rogers · Washington University · R01 · FY2009 · CA
Long-term prediction of prostate cancer death from kallikreins measured in blood
$340,099Hans Gãsta Lilja · Sloan-Kettering Inst Can Research · R33 · FY2011 · CA
Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells
$340,093John Zhong · University Of Southern California · R01 · FY2016 · CA
St.Louis-Cape Girardeau CCOP
$340,029Bethany Sleckman · St.Louis-Cape Girardeau Ccop · U10 · FY2006 · CA
St.Louis-Cape Girardeau CCOP
$340,029St.Louis-Cape Girardeau Ccop · U10 · FY2005 · CA
The Role of CDK5 in Metastasis
$339,993Barry D. Nelkin · Johns Hopkins University · R01 · FY2011 · CA
The Role of CDK5 in Metastasis
$339,993Barry D. Nelkin · Johns Hopkins University · R01 · FY2012 · CA